Vivos Therapeutics Aktie
WKN DE: A2QF3C / ISIN: US92859E1082
|
16.04.2026 04:07:31
|
Vivos Therapeutics Inc Full Year Sales Increase
(RTTNews) - Vivos Therapeutics Inc (VVOS) released Loss for full year of -$21.17 million
The company's earnings came in at -$21.17 million, or -$2.07 per share. This compares with -$11.14 million, or -$2.22 per share, last year.
The company's revenue for the period rose 16.0% to $17.44 million from $15.03 million last year.
Vivos Therapeutics Inc earnings at a glance (GAAP) :
-Earnings: -$21.17 Mln. vs. -$11.14 Mln. last year. -EPS: -$2.07 vs. -$2.22 last year. -Revenue: $17.44 Mln vs. $15.03 Mln last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Vivos Therapeutics Inc Registered Shs
| Keine Nachrichten verfügbar. |